Chronic bronchial infection: The problem of Pseudomonas aeruginosa;Infección bronquial crónica: El problema de

Archivos de Bronconeumologia

Volumn 47, Issue SUPPL. 6, 2011, Pages 8-13

  Cantón, Rafael ^a   Fernández Olmos, Ana ^a   de la Pedrosa, Elia Gómez G ^a   Del Campo, Rosa ^a   Antonia Meseguer, María ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Biofilms; Bronchiectasis; Hypermutation; Persistence; Pseudomonas aeruginosa

Indexed keywords

ANTIINFECTIVE AGENT; AUTACOID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BIOFILM; BRONCHIECTASIS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DISEASE EXACERBATION; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNOSTIMULATION; LUNG FUNCTION; MULTIPLE CYCLE TREATMENT; NEUTROPHIL; NONHUMAN; PSEUDOMONAS AERUGINOSA; QUALITY OF LIFE; RESPIRATORY TRACT MUCOSA;

ANTI-BACTERIAL AGENTS; BIOFILMS; BRONCHIECTASIS; CHRONIC DISEASE; DRUG RESISTANCE, BACTERIAL; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 79959526932     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(11)70029-1     Document Type: Article

References (36)

1. Vendrell M., De Gracia J., Olveira C., Martínez M.A., Girón R., Máiz L., et al. Diagnóstico y tratamiento de las bronchiectasias. Sociedad Española de Neumología y Cirugía Torácica. Arch Bronconeumol 2008, 44:629-640.
2. Pasteur M.C., Bilton D., Hill A.T. British Thoracic Society Bronchiectasis non-CF Guideline Group British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010, 65(Suppl 1):i1-i58.
3. Barker A.F. Bronchiectasis. N Engl J Med 2002, 346:1383-1393.
4. Sethi S., Murphy T.F. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Ver 2001, 14:336-363.
5. Cantón R., Cobos N., De Gracia J., Baquero F., Honorato J., Gartner S., et al. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect 2005, 11:690-703.
6. Angrill J., Agustí C., De Celis R., Rano A., González J., Solé T., et al. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002, 57:15-19.
7. Zoumot Z., Wilson R. Respiratory infection in noncystic fibrosis bronchiectasis. Curr Opin Infect Dis 2010, 23:165-170.
8. King P.T., Holdsworth S.R., Freezer N.J., Villanueva E., Holmes P.W. Microbiologic follow-up study in adult bronchiectasis. Respir Med 2007, 101:1633-1638.
9. Bienvenu T., Sermet-Gaudelus I., Burgel P.R., Hubert D., Crestani B., Bassinet L., et al. Cystic fibrosis transmembrane conductance regulator channel dysfunction in noncystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2010, 181:1078-1084.
10. Fuschillo S., De Felice A., Alzano G. Mucosal inflammation in idiopathic brochiectasis: cellular and molecular mechanisms. Eur Respir J 2008, 31:396-406.
11. Angrill J., Agustí C., De Celis R., Filella X., Rano A., Elena M., et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 2001, 164:1628-1632.
12. Sethi S., Evans N., Grant B.J., Murphy T.F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002, 347:465-471.
13. King P., Holdsworth S., Freezer N., Holmes P. Bronchiectasis. Intern Med J 2006, 36:729-737.
14. Miszkiel K.A., Wells A.U., Rubens M.B., Cole P.J., Hansell D.M. Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study. Thorax 1997, 52:260-264.
15. Davies G., Wells A.U., Doffman S., Watanabe S., Wilson R. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur Respir J 2006, 28:974-979.
16. Wilson C.B., Jones P.W., O'Leary C.J., Hansell D.M., Cole P.J., Wilson R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur Respir J 1997, 10:1754-1760.
17. Martínez-García M.A., Soler-Cataluña J.J., Perpiñá-Tordera M., Román-Sánchez P., Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007, 132:1565-1572.
18. Murphy T.F., Sethi S., Klingman K.L., Brueggemann A.B., Doern G.V. Simultaneous respiratory tract colonization by multiple strains of non typeable Haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy. J Infect Dis 1999, 180:404-409.
19. Martínez-Somalo Martínez-Solano L., Macia M.D., Fajardo A., Oliver A., Martínez J.L. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis 2008, 47:1526-1533.
20. Bilton D., Henig N., Morrissey B., Gotfried M. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Chest 2006, 130:1503-1510.
21. Costerton J.W., Montanaro L., Arciola C.R. Bacterial communications in implant infections: a target for an intelligence war. Int J Artif Organs 2007, 30:757-763.
22. Maciá M.D., Blanquer D., Togores B., Sauleda J., Pérez J.L., Oliver A. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother 2005, 49:3382-3386.
23. Blázquez J. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin Infect Dis 2003, 37:1201-1209.
24. Tanaka M.M., Bergstrom C.T., Levin B.R. The evolution of mutator genes in bacterial populations: the roles of environmental change and timing. Genetics 2003, 164:843-854.
25. Hocquet D., Bertrand X., Köhler T., Talon D., Plésiat P. Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrob Agents Chemother 2003, 47:1887-1894.
26. Oliver A., Cantón R., Campo P., Baquero F., Blázquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288:1251-1254.
27. Hogardt M., Hoboth C., Schmoldt S., Henke C., Bader L., Heesemann J. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis 2007, 195:70-80.
28. García-Castillo M., Del Campo R., Baquero F., Morosini M.I., Turrientes M.C., Zamora J., et al. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients. Clin Microbiol Infect 2010, Jul 29. doi:10.1111/j.1469-0691.2010.03317.x.
29. Branda S.S., Vik S., Friedman L., Kolter R. Biofilms: the matrix revisited. Trends Microbiol 2005, 13:20-26.
30. Davey M.E., Caiazza N.C., O'Toole G.A. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J Bacteriol 2003, 185:1027-1036.
31. Stoodley P., Sauer K., Davies D.G., Costerton J.W. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002, 56:187-209.
32. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15:167-193.
33. Fux C.A., Stoodley P., Hall-Stoodley L., Costerton J.W. Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther 2003, 1:667-683.
34. Moskowitz S.M., Foster J.M., Emerson J.C., Gibson R.L., Burns J.L. Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection. J Antimicrob Chemother 2005, 56:879-886.
35. Murray T.S., Egan M., Kazmierczak B.I. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Curr Opin Pediatr 2007, 19:83-88.
36. Høiby N., Bjarnsholt T., Givskov M., Molin S., Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010, 35:322-332.